Stockreport

ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System [Yahoo! Finance]

Abbott Laboratories  (ABT) 
Last abbott laboratories earnings: 4/16 07:30 am Check Earnings Report
US:NYSE Investor Relations: abbott.com/investors.html
PDF treatment of severe calcification in coronary arteries prior to stenting. The TECTONIC Coronary Artery Disease (“CAD”) Intravascular Lithotripsy (IVL) clinical trial wil [Read more]